Getting to First-in-Human for Small Molecules and Biologics
Getting to First-in-Human for Small Molecules and Biologics
|
Loading...
Lütfen bekleyiniz...
Type
Size

İlgili Videolar

Getting to First-in-Human for Small Molecules and Biologics

Getting to First-in-Human for Small Molecules and Biologics

|
Designing First-In-Human Trials for Small Molecules and Biologics

Designing First-In-Human Trials for Small Molecules and Biologics

|
Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

Nonclinical Safety Assessment for Small Molecules and Biologic Drug Development (6of14) REdI 2018

|
Small vs. large molecules? The difference explained

Small vs. large molecules? The difference explained

|
FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

FDA’s Clinical Regulatory Perspective: Designing First-In-Human Trial for Cellular and Gene Therapy

|
Small Molecules, Biologics, and Vaccines: Three Uniquely Divergent Roads to FDA CMC Approval

Small Molecules, Biologics, and Vaccines: Three Uniquely Divergent Roads to FDA CMC Approval

|
Blueprint Neurotherapeutics Network for Small Molecules Q&A webinar

Blueprint Neurotherapeutics Network for Small Molecules Q&A webinar

|
Found in Translation Building an Early Development Strategy for Complex Biologics

Found in Translation Building an Early Development Strategy for Complex Biologics

|
BT 101 - Lecture 4.1

BT 101 - Lecture 4.1

|
Assembling the Best Team to Navigate through Preclinical Development

Assembling the Best Team to Navigate through Preclinical Development

|
Webinar - Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic

Webinar - Managing Challenging Bioanalysis for PK/PD assessments for Phase I Biologic

|
Challenges in Drug Development for ALS

Challenges in Drug Development for ALS

|
BPN for Small Molecules Q&A Webinar

BPN for Small Molecules Q&A Webinar

|
Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy Cavagnaro

Stem Cell Clinical Trials: Designing Preclinical Studies for First in Human Trials | Joy Cavagnaro

|
Preparing, Initiating, and Approaching the Pre-IND Meeting

Preparing, Initiating, and Approaching the Pre-IND Meeting

|
Careers in Biotech & Pharma: Exploring Approaches to Developing Pharmaceuticals

Careers in Biotech & Pharma: Exploring Approaches to Developing Pharmaceuticals

|
Biologics and Small Molecules for Autoimmune Diseases

Biologics and Small Molecules for Autoimmune Diseases

|
Biologics, biosimilars, and small molecules

Biologics, biosimilars, and small molecules

|
Day 5: Goalpost: First in Human Clinical Trial

Day 5: Goalpost: First in Human Clinical Trial

|
First in Human Pharmacokinetic Evaluation of Antiretroviral Solid Drug Nanoparticles for Dose...

First in Human Pharmacokinetic Evaluation of Antiretroviral Solid Drug Nanoparticles for Dose...

|
Copyright. All rights reserved © 2025
Rosebank, Johannesburg, South Africa